The Centers for Medicare & Medicaid Services yesterday released a request for applications to participate in the Part D Payment Modernization Model in calendar year 2022.

The five-year model, which began this month, will test new incentives for Medicare prescription drug plans, patients and providers to choose drugs with lower list prices. For CY 2022, CMS said the model will test new flexibilities to better align Part D formularies with other pharmacy benefit designs in the commercial and individual markets, and remove the model’s downside risk.

Interested Part D sponsors should submit a non-binding notice of intent to apply by March 1 and an application by April 16, 2021.

Related News Articles

Perspective
Public
Every health care provider strives to deliver their patients the best possible care, but not all providers offer the same level or complexity of care. Current…
Headline
A JAMA internal medicine study published Sept. 8 found that since the COVID-19 pandemic, Medicare Advantage beneficiaries have been experiencing longer…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 3 released a study conducted by KNG Health Consulting that found Medicare patients who receive care in a hospital outpatient department are more…
Headline
The AHA Aug. 28 expressed support for the Preserving Patient Access to Accountable Care Act in comments to House and Senate sponsors of the bill. The…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…